Regeneron and AstraZeneca to Research, Develop and Commercialize New Small Molecule ...

Retrieved on: 2021-07-27 11:00:45

Tags for this article:

Health sciences

Health care

Life Sciences

Monoclonal antibodies

Sanofi

Breakthrough therapy

Regeneron Pharmaceuticals

George Yancopoulos

Casirivimab/imdevimab

Aflibercept

Alirocumab

Pharmaceutical industry

REGENERON GENETICS CENTER

Click the tags to see associated articles and topics

Regeneron and AstraZeneca to Research, Develop and Commercialize New Small Molecule .... View article details on HISWAI: https://www.prnewswire.com/news-releases/regeneron-and-astrazeneca-to-research-develop-and-commercialize-new-small-molecule-medicines-for-obesity-301341168.html

Excerpt

TARRYTOWN, N.Y., July 27, 2021 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and AstraZeneca today announced that the ...

Article found on: www.prnewswire.com

View Original Article